The Benefit of Menopausal Hormone Therapy on Bone Density and Microarchitecture Persists After its Withdrawal | Zendy

Georgios Papadakis | Zendy; Didier Hans | Zendy; Elena González Rodríguez | Zendy; Péter Vollenweider | Zendy; Gérard Waeber | Zendy; Pedro MarquesVidal | Zendy; Olivier Lamy | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Benefit of Menopausal Hormone Therapy on Bone Density and Microarchitecture Persists After its Withdrawal

Author(s) -

Georgios Papadakis,

Didier Hans,

Elena González Rodríguez,

Péter Vollenweider,

Gérard Waeber,

Pedro MarquesVidal,

Olivier Lamy

Publication year - 2016

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2016-2695

Subject(s) - trabecular bone score , medicine , bone mineral , femoral neck , lumbar spine , urology , bone density , cohort , osteoporosis , hip bone , body mass index , quantitative computed tomography , endocrinology , surgery

Menopausal hormone therapy (MHT) favorably affects bone mineral density (BMD). Whether MHT also affects bone microarchitecture, as assessed by trabecular bone score (TBS), has never been evaluated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research